The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with poor prognosis. Therefore, indicators that can be used for the early prediction of the prognosis of PDAC are needed. Peroxiredoxin (PRDX) 4 is a secretion-type antioxidant enzyme located in the cytoplasmic endoplasmic reticulum. Recent...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Histology and histopathology 2023-12, Vol.38 (12), p.1415-1427
Hauptverfasser:	Han, Jia, Itoh, Tohru, Shioya, Akihiro, Sakurai, Masaru, Oyama, Takeru, Kumagai, Motona, Takamura, Hiroyuki, Okuro, Masashi, Mukai, Tsuyoshi, Kitakata, Hidekazu, Inagaki, Masaru, Higashi, Michiyo, Guo, Xin, Yamada, Sohsuke
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - metabolism Carcinoma, Pancreatic Ductal - pathology Humans Pancreatic Neoplasms - pathology Perilipin-2 Peroxiredoxins - metabolism Prognosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!